Algo version: 0.98b
PT Millennium Pharmacon is listed at the JKT Exchange
PT Millennium Pharmacon [SDPC.JK]
JKT Sector: Healthcare Industry:Medical Distribution

Is PT Millennium Pharmacon stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, PT Millennium Pharmacon pays dividends. Last time was Thursday 4th of July 2024 where the investors holding the stock on Tuesday 11th of June 2024 were paid IDR2.5 per share. Over the last 9 times between 2016 and 2024, PT Millennium Pharmacon has paid IDR16.90683 with an average of IDR1.88 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PT Millennium Pharmacon 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was IDR106.00, you would have made a profit of IDR27.00 per share or 25.47%

Yes, the average daily trading liquidity for PT Millennium Pharmacon is IDR355 179 thousand. You should therefore be able to get in and out of your positions relatively fast.

PT Millennium Pharmacon has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company has a very low net profit margin of 0.96%, which is challenging.

We have calculated the inflation risk for PT Millennium Pharmacon to be medium [0.65 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.